Neuromuscular junction

Wednesday, September 14, 2022
PARALLEL 1
14-PM-Parallel-1 4:30 PM > 6:00 PM Neuromuscular junction Apollon Auditorium

4:30 PM S13L1 New treatments for autoimmune myasthenia gravis > E. Emilien DELMONT (Marseille, France) 5:00 PM S13L2 Use of human pluripotent stem cells for Neuromuscular Disorders > C. Cécile MARTINAT (Evry, France) 5:30 PM S13L3 Targeting the neuromuscular junction (NMJ) to treat congenital myasthenic syndromes and inherited motor neuropathies with NMJ dysfunction > S. Sally SPENDIFF (Ottawa, Canada)

Copyright © key4events - All rights reserved